https://www.biospace.com/fda/fdas-bespoke-pathway-to-focus-on-gene-editing-and-rna-based-treatments-for-rare-diseases
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases - BioSpace
Feb 24, 2026 - The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay Prasad in November, was criticized...
pathway to focus